A clinical trial with sub-cutaneous Plasminogen in patients with diabetic foot ulcers

Trial Profile

A clinical trial with sub-cutaneous Plasminogen in patients with diabetic foot ulcers

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Mar 2018

At a glance

  • Drugs Plasminogen (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Mar 2018 According to a ProMetic Life Sciences media release, study is being conducted in one study center in Sweden, under the supervision of Dr. Jan Apelqvist,from the Department of Endocrinology, Division of Clinical Sciences at Skane University Hospital in Malmo, Sweden.
    • 26 Feb 2018 New trial record
    • 20 Feb 2018 According to a ProMetic Life Sciences media release, interim clinical data readouts are expected later this year.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top